Merck: Keytruda's Sales Projections Outweigh Competitive And Patent Risks
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
Scientists Discover Protein That Could Help Stop Aggressive Prostate Cancer
A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...
News Medical14h
MRI-guided SBRT reduces side effects in prostate cancer treatment
After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...
healthday1d
Overtreatment Common for Older Men With Prostate Cancer
Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new s ...